In this episode, we discuss the new drug class of Novel Oral Anticoagulants (NOACs), which include dabigatran (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis).
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast","authorlink":""},"src":"https:\/\/traffic.libsyn.com\/secure\/helixtalk\/003_-_NOACs.mp3?dest-id=187168","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202310\/51d8ce-5810-087d-300941_800.png"},"title":"003 - Novel Oral Anticoagulants (NOACs)","link":"javascript:;","id":"item-685502"}]
